论文部分内容阅读
近十年来,由于新的有效抗肿瘤药物出现和给药方法的改进以及骨髓移植和单克隆抗体的临床应用使急性白血病(简称AL)的完全缓解率(CR)和长期存活率有了显著
In recent ten years, the complete response rate (CR) and long-term survival rate of acute leukemia (AL) have been significantly improved due to the emergence and administration of new and effective antitumor drugs and the clinical application of bone marrow transplantation and monoclonal antibody